Published in J Clin Microbiol on June 01, 1995
Challenges and opportunities in estimating viral genetic diversity from next-generation sequencing data. Front Microbiol (2012) 1.89
Performance characteristics of the TRUGENE HIV-1 Genotyping Kit and the Opengene DNA Sequencing System. J Clin Microbiol (2003) 1.73
Determinations of levels of human immunodeficiency virus type 1 RNA in plasma: reassessment of parameters affecting assay outcome. TUBE Meeting Workshop Attendees. Technology Utilization for HIV-1 Blood Evaluation and Standardization in Pediatrics. J Clin Microbiol (1998) 1.58
Optimization of specimen-handling procedures for accurate quantitation of levels of human immunodeficiency virus RNA in plasma by reverse transcriptase PCR. J Clin Microbiol (1998) 1.53
Highly sensitive multiplex assay for detection of human immunodeficiency virus type 1 and hepatitis C virus RNA. J Clin Microbiol (2002) 1.46
Effects of specimen collection, processing, and storage conditions on stability of human immunodeficiency virus type 1 RNA levels in plasma. J Clin Microbiol (1997) 1.43
Circulating transcriptome reveals markers of atherosclerosis. Proc Natl Acad Sci U S A (2005) 1.27
Stability of plasma human immunodeficiency virus load in VACUTAINER PPT plasma preparation tubes during overnight shipment. J Clin Microbiol (2000) 1.18
Effects of anticoagulant, processing delay, and assay method (branched DNA versus reverse transcriptase PCR) on measurement of human immunodeficiency virus type 1 RNA levels in plasma. J Clin Microbiol (1999) 1.07
Stability of human immunodeficiency virus RNA in blood specimens as measured by a commercial PCR-based assay. J Clin Microbiol (1998) 0.99
Changes in anti-viral effectiveness of interferon after dose reduction in chronic hepatitis C patients: a case control study. BMC Gastroenterol (2001) 0.98
Assessment of hepatitis B virus DNA stability in serum by the Chiron Quantiplex branched-DNA assay. J Clin Microbiol (1998) 0.96
Plasma versus serum for detection of herpes simplex virus type 2-specific immunoglobulin G antibodies with a glycoprotein G2-based enzyme immunoassay. J Clin Microbiol (2003) 0.92
Evaluation of the VACUTAINER PPT Plasma Preparation Tube for use with the Bayer VERSANT assay for quantification of human immunodeficiency virus type 1 RNA. J Clin Microbiol (2005) 0.91
Immune cell subsets and their gene expression profiles from human PBMC isolated by Vacutainer Cell Preparation Tube (CPT™) and standard density gradient. BMC Immunol (2015) 0.85
Associations of common variants in the BST2 region with HIV-1 acquisition in African American and European American people who inject drugs. AIDS (2015) 0.85
Intra- and interlaboratory variabilities of results obtained with the Quantiplex human immunodeficiency virus type 1 RNA bDNA assay, version 3.0. Clin Diagn Lab Immunol (2001) 0.84
Comparison of blood collected in acid-citrate-dextrose and EDTA for use in human immunodeficiency virus peripheral blood mononuclear cell cultures. J Clin Microbiol (2000) 0.82
An optimized sensitive method for quantitation of DNA/RNA viruses in heparinized and cryopreserved plasma. J Virol Methods (2011) 0.80
Expanding access to HIV viral load testing: a systematic review of RNA stability in EDTA tubes and PPT beyond current time and temperature thresholds. PLoS One (2014) 0.79
Investigation of effects of acid citrate dextrose and EDTA on ability to quantitatively culture human immunodeficiency virus. J Clin Microbiol (2000) 0.75
TaqMan real-time reverse transcription-PCR and JDVp26 antigen capture enzyme-linked immunosorbent assay to quantify Jembrana disease virus load during the acute phase of in vivo infection. J Clin Microbiol (2005) 0.75
High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science (1993) 12.22
Inhibition of human immunodeficiency virus gene amplification by heparin. J Clin Microbiol (1991) 3.32
Reduction in plasma human immunodeficiency virus ribonucleic acid after dideoxynucleoside therapy as determined by the polymerase chain reaction. J Clin Invest (1991) 1.85
Cell-free plasma human immunodeficiency virus type 1 titer assessed by culture and immunocapture-reverse transcription-polymerase chain reaction. J Clin Microbiol (1993) 1.53
Direct and quantitative detection of HIV-1 RNA in human plasma with a branched DNA signal amplification assay. AIDS (1993) 1.42
Infectious decay of human immunodeficiency virus type 1 in plasma. J Infect Dis (1993) 1.36
Diurnal and short-term stability of HIV virus load as measured by gene amplification. J Acquir Immune Defic Syndr (1994) 1.29
Effect of platelet-associated virus on assays of HIV-1 in plasma. Science (1993) 1.26
Stabilities of quantitative plasma culture for human immunodeficiency virus, RNA, and p24 antigen from samples collected in VACUTAINER CPT and standard VACUTAINER tubes. J Clin Microbiol (1994) 1.16
Loss of infectivity ex vivo in plasma of human immunodeficiency virus-infected patients correlates with a high CD4 cell count. J Infect Dis (1993) 1.06
Stability of infectious HIV in clinical samples and isolation from small volumes of whole blood. J Clin Pathol (1994) 0.98
Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet (1995) 21.03
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet (1999) 18.20
Toxic-shock syndrome associated with phage-group-I Staphylococci. Lancet (1978) 10.25
Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial. Lancet (2009) 7.96
In vitro synthesis and secretion of lysozyme by mononuclear phagocytes. J Exp Med (1974) 7.43
Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012). AIDS (2001) 5.31
Evaluation of a quality assurance program for quantitation of human immunodeficiency virus type 1 RNA in plasma by the AIDS Clinical Trials Group virology laboratories. J Clin Microbiol (1996) 4.81
Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa. Lancet (1999) 4.61
The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team. N Engl J Med (1996) 4.03
Indicators of socioeconomic status for adolescents: the WHO Health Behaviour in School-aged Children Survey. Health Educ Res (1997) 3.66
"A bit more truthful": the validity of adolescent sexual behaviour data collected in rural northern Tanzania using five methods. Sex Transm Infect (2004) 3.37
Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Human Skin Equivalent Investigators Group. Arch Dermatol (1998) 3.26
Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania. Lancet (1998) 3.22
Genotypic identification of pathogenic Mycobacterium species by using a nonradioactive oligonucleotide probe. J Clin Microbiol (1991) 2.90
Reforming athletic training education. J Athl Train (1997) 2.87
Do corals lie about their age? Some demographic consequences of partial mortality, fission, and fusion. Science (1980) 2.84
Is antenatal syphilis screening still cost effective in sub-Saharan Africa. Sex Transm Infect (2003) 2.77
Hurricane Allen's Impact on Jamaican Coral Reefs. Science (1981) 2.76
Microarray analysis of developing Arabidopsis seeds. Plant Physiol (2000) 2.62
Absolute levels and ratios of proinflammatory and anti-inflammatory cytokine production in vitro predict clinical immunity to Plasmodium falciparum malaria. J Infect Dis (2002) 2.61
Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group. N Engl J Med (1997) 2.55
An enhanced-sensitivity branched-DNA assay for quantification of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol (1996) 2.49
A whole blood immunoassay using gold nanoshells. Anal Chem (2003) 2.45
Defective prohormone processing and altered pancreatic islet morphology in mice lacking active SPC2. Proc Natl Acad Sci U S A (1997) 2.42
A new set of Arabidopsis expressed sequence tags from developing seeds. The metabolic pathway from carbohydrates to seed oil. Plant Physiol (2000) 2.39
Antibody to herpes simplex virus type 2 as a marker of sexual risk behavior in rural Tanzania. J Infect Dis (1999) 2.37
The impact of active herpes simplex virus infection on human immunodeficiency virus load. J Infect Dis (1997) 2.31
Risk assessment and other screening options for gonorrhoea and chlamydial infections in women attending rural Tanzanian antenatal clinics. Bull World Health Organ (1995) 2.29
A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006). AIDS (1999) 2.23
Multicenter evaluation of quantification methods for plasma human immunodeficiency virus type 1 RNA. J Infect Dis (1994) 2.15
Baseline survey of sexually transmitted infections in a cohort of female bar workers in Mbeya Region, Tanzania. Sex Transm Infect (2003) 2.14
The frequency of the fragile X chromosome among schoolchildren in Coventry. J Med Genet (1986) 2.06
Sexual behaviour patterns and other risk factors for HIV infection in rural Tanzania: a case-control study. AIDS (1997) 2.05
Mononuclear leukocytes preferentially bind via CD44 to hyaluronan on human intestinal mucosal smooth muscle cells after virus infection or treatment with poly(I.C). J Biol Chem (1999) 2.01
Translating global health research aims into action: the example of the ALPHA network. Trop Med Int Health (2010) 1.99
Male circumcision and susceptibility to HIV infection among men in Tanzania. AIDS (1997) 1.97
Golgi/granule processing of peptide hormone and neuropeptide precursors: a minireview. J Cell Biochem (1984) 1.93
Impact of human immunodeficiency virus type 1 (hiv-1) subtype on women receiving single-dose nevirapine prophylaxis to prevent hiv-1 vertical transmission (hiv network for prevention trials 012 study). J Infect Dis (2001) 1.93
Population incidence and segregation ratios in the Martin-Bell syndrome. Am J Med Genet (1986) 1.86
Performance characteristics of serologic tests for human immunodeficiency virus type 1 (HIV-1) antibody among Minnesota blood donors. Public health and clinical implications. Ann Intern Med (1989) 1.84
Malaria prevalence is inversely related to vector density in The Gambia, West Africa. Trans R Soc Trop Med Hyg (1995) 1.82
A community study of severe mental retardation in the West Midlands and the importance of the fragile X chromosome in its aetiology. J Med Genet (1985) 1.80
Diversity and extinction of tropical american mollusks and emergence of the isthmus of panama. Science (1993) 1.79
Validity of The Health Improvement Network (THIN) for the study of psoriasis. Br J Dermatol (2011) 1.78
Sexual and reproductive health among primary and secondary school pupils in Mwanza, Tanzania: need for intervention. AIDS Care (1998) 1.75
Chromatin fractionation procedure that yields nucleosomes containing near-stoichiometric amounts of high mobility group nonhistone chromosomal proteins. Biochemistry (1979) 1.72
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Impact of tuberculosis (TB) on HIV-1 activity in dually infected patients. Clin Exp Immunol (2001) 1.67
Proinsulin processing by the subtilisin-related proprotein convertases furin, PC2, and PC3. Proc Natl Acad Sci U S A (1992) 1.65
Asymptomatic gonorrhoea and chlamydial infection in rural Tanzanian men. BMJ (1996) 1.63
Evolutionary significance of morphospecies: a test with cheilostome bryozoa. Science (1990) 1.62
Rationale and design of the MEMA kwa Vijana adolescent sexual and reproductive health intervention in Mwanza Region, Tanzania. AIDS Care (2006) 1.62
A trial of a group A plus group C meningococcal polysaccharide-protein conjugate vaccine in African infants. J Infect Dis (1995) 1.61
A community trial of the impact of improved sexually transmitted disease treatment on the HIV epidemic in rural Tanzania: 2. Baseline survey results. AIDS (1995) 1.60
Absolute copy number and relative change in determinations of human immunodeficiency virus type 1 RNA in plasma: effect of an external standard on kit comparisons. J Clin Microbiol (1998) 1.60
Fat and carbohydrate metabolism during exercise in elderly and young subjects. Am J Physiol (1996) 1.59
Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection. Pediatr Infect Dis J (1999) 1.57
A malaria control trial using insecticide-treated bed nets and targeted chemoprophylaxis in a rural area of The Gambia, west Africa. 4. Perceptions of the causes of malaria and of its treatment and prevention in the study area. Trans R Soc Trop Med Hyg (1993) 1.56
Nucleoside incorporation into strain L cells: inhibition by pleuropneumonia-like organisms. Science (1965) 1.56
The Immunology Case Registry. J Clin Epidemiol (2001) 1.56
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Prostitutes and their clients: a Gambian survey. Soc Sci Med (1992) 1.55
Multilaboratory comparison of hepatitis C virus viral load assays. J Clin Microbiol (2006) 1.53
A critical analysis of the use of radiation inactivation to measure the mass of protein. Radiat Res (1995) 1.52
Incomplete processing of proinsulin to insulin accompanied by elevation of Des-31,32 proinsulin intermediates in islets of mice lacking active PC2. J Biol Chem (1998) 1.51
Cyclosporine as maintenance therapy in patients with severe psoriasis. J Am Acad Dermatol (1997) 1.51
Low mortality risk but high loss to follow-up among patients in the Tanzanian national HIV care and treatment programme. Trop Med Int Health (2012) 1.51
Performance of the applied biosystems ViroSeq human immunodeficiency virus type 1 (HIV-1) genotyping system for sequence-based analysis of HIV-1 in pediatric plasma samples. J Clin Microbiol (2001) 1.47
Severe defect in proglucagon processing in islet A-cells of prohormone convertase 2 null mice. J Biol Chem (2001) 1.45
Comparison of quantitative and qualitative PCR assays for cytomegalovirus DNA in plasma. J Clin Microbiol (2001) 1.45
The epidemiology of HIV infection in a rural area of Guinea-Bissau. AIDS (1993) 1.45
Two strategies for correcting refractive errors in school students in Tanzania: randomised comparison, with implications for screening programmes. Br J Ophthalmol (2008) 1.44
Welfare reform: advocacy and intervention in the health care setting. Public Health Rep (2000) 1.44
Effects of specimen collection, processing, and storage conditions on stability of human immunodeficiency virus type 1 RNA levels in plasma. J Clin Microbiol (1997) 1.43
Ion transport induced by light and antibiotics IN CHROMATOPHORES FROM Rhodospirillum rubrum. Eur J Biochem (1968) 1.42
Clinical evaluation of branched DNA signal amplification for quantifying HIV type 1 in human plasma. AIDS Res Hum Retroviruses (1995) 1.42
Risk factors for HIV infection in homosexual men: the Cleveland men's study of risks in a low-prevalence area. Cleve Clin J Med (1992) 1.41
Pressure ulcers: the great insult. Adv Wound Care (1996) 1.38
Bacteriuria and leucocyte excretion in the newborn. J Ir Med Assoc (1968) 1.38
Tennis elbow: incidence in local league players. Br J Sports Med (1981) 1.36
Electron flow to dimethylsulphoxide or trimethylamine-N-oxide generates a membrane potential in Rhodopseudomonas capsulata. Arch Microbiol (1983) 1.35
Movement of Anopheles gambiae s.l. malaria vectors between villages in The Gambia. Med Vet Entomol (1995) 1.35
The effects of hemoglobin genotype and ABO blood group on the formation of rosettes by Plasmodium falciparum-infected red blood cells. Am J Trop Med Hyg (1993) 1.33
A process evaluation of a school-based adolescent sexual health intervention in rural Tanzania: the MEMA kwa Vijana programme. Health Educ Res (2006) 1.33
Dried-plasma transport using a novel matrix and collection system for human immunodeficiency virus and hepatitis C virus virologic testing. J Clin Microbiol (2009) 1.32
Evidence by allelic association-dependent methods for a type 1 diabetes polygene (IDDM6) on chromosome 18q21. Hum Mol Genet (1997) 1.32
Designing studies to estimate the penetrance of an identified autosomal dominant mutation: cohort, case-control, and genotyped-proband designs. Genet Epidemiol (1999) 1.31
Nonisotopic hybridization assay for determination of relative amounts of genotypic human immunodeficiency virus type 1 zidovudine resistance. J Clin Microbiol (1995) 1.31
The effects of iron supplementation during pregnancy, given by traditional birth attendants, on the prevalence of anaemia and malaria. Trans R Soc Trop Med Hyg (1995) 1.30
Multicenter comparison of the digene hybrid capture CMV DNA assay (version 2.0), the pp65 antigenemia assay, and cell culture for detection of cytomegalovirus viremia. J Clin Microbiol (1999) 1.30
Safety, stability, and efficacy of noncapsulated mutants of Actinobacillus pleuropneumoniae for use in live vaccines. Infect Immun (1993) 1.30
Children with the fragile X chromosome at schools for the mildly mentally retarded. Dev Med Child Neurol (1987) 1.29
Diurnal and short-term stability of HIV virus load as measured by gene amplification. J Acquir Immune Defic Syndr (1994) 1.29
Risk scores to detect cervical infections in urban antenatal clinic attenders in Mwanza, Tanzania. Sex Transm Infect (1998) 1.29
HIV-2-infected patients survive longer than HIV-1-infected patients. AIDS (1994) 1.28